I now have comprehensive information. Here is a full, well-organized answer.
Common Cold: Drug Use & Management
Overview
The common cold is caused primarily by rhinoviruses (30–60% of cases), with coronaviruses, parainfluenza viruses, RSV, influenza, adenoviruses, and metapneumoviruses accounting for the rest. No treatment has been proven to significantly reduce the duration or severity of illness. Antibiotics are of no benefit and should not be prescribed. The goal is symptomatic relief.
Drug-by-Drug Guide
1. Decongestants (Nasal Congestion)
| Route | Drug | Dose | Notes |
|---|
| Topical | Oxymetazoline, xylometazoline | 2–3 sprays (0.05%) every 12 hr, max 3 days | More effective than oral; rebound congestion (rhinitis medicamentosa) with prolonged use |
| Oral | Pseudoephedrine | 60 mg every 4–6 hr (max 240 mg/day) | CNS stimulation → insomnia, agitation, palpitations |
Caution: Avoid oral decongestants in patients with hypertension or heart disease. Nasal saline is safe but offers modest benefit.
2. Antihistamines (Rhinorrhea / Sneezing)
- First-generation (sedating): e.g., chlorpheniramine 4 mg every 4–6 hr (max 24 mg/day)
- Mild benefit on rhinorrhea due to anticholinergic properties — dries secretions
- Side effects: sedation, dry eyes, dry mouth
- Second-generation (non-sedating): e.g., loratadine, cetirizine
- Not effective for cold-related rhinorrhea (lack anticholinergic activity)
3. Anticholinergic (Rhinorrhea)
- Intranasal ipratropium bromide (0.06%) — 2 sprays per nostril every 6–8 hr
- Reduces rhinorrhea by approximately 25% by blocking cholinergic glandular secretion
- Side effects: nasal dryness, irritation, occasional nosebleeds
4. Cough Suppressants & Expectorants
| Drug | Class | Evidence |
|---|
| Dextromethorphan | Antitussive | Limited; modest placebo effect noted |
| Codeine | Opioid antitussive | Limited; risk of dependence |
| Guaifenesin | Expectorant | Insufficient data |
| Ipratropium (nasal) | Anticholinergic | Useful if cough is from postnasal drip |
| Inhaled bronchodilators | β₂-agonist | Consider if virus-induced reactive airway disease |
Evidence for all cough suppressants in the common cold is quite limited. A substantial placebo effect means patient preference can guide safe agent choice.
5. Analgesics / Antipyretics (Sore Throat, Headache, Myalgias, Fever)
| Drug | Dose | Notes |
|---|
| Acetaminophen | 650–1000 mg every 4–6 hr | Preferred first-line for pain/fever |
| Ibuprofen | 200–400 mg every 4–6 hr | Equally effective; risk of GI upset, GI bleeding, nephrotoxicity |
| Naproxen | 275–550 mg every 6–8 hr | Similar to ibuprofen |
6. Combination OTC Products
Products combining analgesics + decongestants + antihistamines ± antitussives (e.g., DayQuil, NyQuil, Mucinex Fast-Max) may have modest benefit over placebo, but:
- Targeted, symptom-specific therapy is preferred
- Reduces unnecessary side effects and cost
- Avoid in children ≤ 6 years — associated with potential harm and deaths; not recommended < 4 years per AAFP guidelines
7. Zinc
- Zinc lozenges (zinc acetate or zinc gluconate, ≥ 75 mg/day elemental zinc) may improve recovery rates by ≥ 20% if started early
- Side effects: bad taste, sore mouth, nausea
- Intranasal zinc: risk of nasal irritation, nosebleeds — not recommended
8. Agents with No Proven Benefit
| Agent | Verdict |
|---|
| Vitamin C | Not proven to prevent or treat the common cold |
| Echinacea | No proven benefit |
| Antibiotics | No benefit; inappropriate prescribing remains common |
| Antivirals (e.g., oseltamivir) | Not useful for cold (use only for confirmed influenza) |
| Herbal antitussives | Limited/controversial evidence |
Special Populations
- Children < 4 years: OTC cough and cold medicines are contraindicated (no proven benefit; significant safety risks)
- Children 4–6 years: Use with caution; not generally recommended
- Hypertensive/cardiac patients: Avoid oral and topical sympathomimetic decongestants
Prevention (Non-Drug)
- Handwashing — most effective non-pharmacological measure
- Physical distancing and mask-wearing reduce transmission
- Vitamin D (400–1000 IU/day regularly) may modestly reduce incidence
- Probiotics have at most a modest preventive benefit
Sources: Goldman-Cecil Medicine, 26th ed.; Tintinalli's Emergency Medicine; AAFP Treatment of the Common Cold